Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
about
PPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart.Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.Relaxation of human pulmonary arteries by PPARγ agonists.Peroxisome Proliferator-Activated Receptor γ Regulates Chronic Alcohol-Induced Alveolar Macrophage Dysfunction.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Reactive oxygen species as therapeutic targets in pulmonary hypertension.Effect of Pranayama on Ppar-γ, Nf-κB Expressions and Red Complex Microorganisms in Patients with Chronic Periodontitis - A Clinical Trial.Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.Evidence Linking the Role of Placental Expressions of Peroxisome Proliferator-Activated Receptor-γ and Nuclear Factor-Kappa B in the Pathogenesis of Preeclampsia Associated With Periodontitis.Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.PPARγ Regulates Mitochondrial Structure and Function and HPASMC Proliferation.BIRC5 is a novel target of peroxisome proliferator‑activated receptor γ in brain microvascular endothelium cells during cerebral ischemia.Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.
P2860
Q33738569-F9C80C4C-FA9C-428D-8709-E4533BA780A8Q33831356-DB92BB6F-66C2-477B-B379-37862456D132Q35711530-90BE3A05-4C04-46E5-A750-053D8794BF4DQ36755896-083466E5-42D2-4F9D-9A9A-2B05C34D2DB5Q37088261-5A140D7E-9BED-4241-AC1D-314A589B1F34Q37607478-478CBAE5-7DCB-419C-86B9-065201124A9FQ38074770-9C0CCD05-2FED-4451-98C3-565BF7A1CC8EQ38648553-BFE9FC6F-9E43-4051-8997-DA80D3DC3322Q39150404-0B85D96E-206B-4147-A4D5-1D583F2E352CQ39768212-1CE1CC8D-DFF9-414C-8888-5C933FBEB11AQ43182141-9260B76A-662C-49AF-82DC-602F9CD6B079Q47074392-AB254A03-BB44-4166-B2D4-86364DEC96E2Q47356839-2D1CA139-224C-4D79-B36B-0A65680FAE2EQ48015117-CD99535A-558E-4F0E-8196-B1FD105889B4Q50416961-50800ECC-0778-4547-A687-02EA56D9D71D
P2860
Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@ast
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@en
Is peroxisome proliferator-activated receptor gamma
@nl
type
label
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@ast
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@en
Is peroxisome proliferator-activated receptor gamma
@nl
prefLabel
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@ast
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@en
Is peroxisome proliferator-activated receptor gamma
@nl
P2093
P2860
P356
P1476
Is peroxisome proliferator-act ...... ent of pulmonary hypertension?
@en
P2093
C Michael Hart
David E Green
Roy L Sutliff
P2860
P356
10.4103/2045-8932.78101
P577
2011-01-01T00:00:00Z